this announcement seems to be for the company to meet it's continuous disclosure obligations and to potentially dampen the current share price enthusiasm that has been going for the last week.
Ann: Update on FDA New Drug Application Review for Illuccix, page-2
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$22.99 |
Change
0.130(0.57%) |
Mkt cap ! $7.694B | |||
| Open | High | Low | Value | Volume |
| $22.97 | $23.46 | $22.89 | $22.02M | 952.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3712 | $22.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $23.06 | 540 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| TLX (ASX) Chart |